Cooper's (CBE) CooperVision Said to Have Addressed FDA Volations

CooperVision, Inc., a subsidiary of The Cooper Companies, Inc. (NYSE: CBE), received a letter from the United States Food and Drug Administration regarding the Warning Letter issued on December 5, 2011. The FDA reported that it has completed an evaluation of the Company’s corrective actions, and it appears the Company has addressed the violations contained in the letter.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• FDA authorizes 11 ZYN Ultra nicotine pouches for Philip Morris
• BIGG Digital Assets to rename as Surge Digital, consolidate shares
• Boeing names Ryan Shedd as new SVP and controller